Biotime COVID-19 Prognosis Therapy Solution
July 02 , 2020
After the outbreak of COVID-19, Biotime actively took action to fight against the pandemic and successfully launched COVID-19 related products solution.

Biotime COVID-19 Prognosis Therapy Solution including D-Dimer, PCT, IL-6, CRP, and Ferritin rapid quantitative test reagents and two analyzers, with which, the results come in 3 to 20 mins. these test reagents could be the early and helpful biomarkers to improve the management of COVID-19 patients.


The clinical significance of the test reagents are as follow:
D-Dimer: D-Dimer levels on admission to predict in-hospital mortality in patients with COVID-19.
CRP: Systemic inflammation, as measured by CRP, is strongly associated with VTE, AKI, critical illness, and mortality in COVID-19.
IL-6: Serum IL-6 concentration is closely associated with the severity of COVID-19.
Ferritin: Early analysis of Ferritin levels in patients with COVID-19 might effectively define the severity of the disease.
PCT: PCT may be a valuable tool in identifying COVID-19 patients at high risk for clinical deterioration or patients at risk for bacterial co-infection.

Biotime COVID-19 solution not only cares about the therapy of the patients who catch COVID-19 but also provides guiding advice and treatment solution for the doctors.



Reference:

[1] Zhang,L et al. D-dimer levels on admission to predict in-hospital mortality in patients with Covid-19. Journal of thrombosis and haemostasis:JTH, 18(6), 1324-1329.
[2] Nathaniel R Smilowitz et al. C-reactive protein and clinical outcomes in patients with COVID-19
[3] Sun, H et al. Serum Interleukin-6 Concentrations and the Severity of COVID-19 Pneumonia: A Retrospective Study at a Single Center in Bengbu City, Anhui Province, China, in
January and February 2020
[4] Bozkurt F, Tercan M, Patmano G, et al. (January 21, 2021) Can Ferritin Levels Predict the Severity of Illness in Patients With COVID-19?. Cureus 13(1): e12832. doi:10.7759/cureus.12832
[5] Philipp Schuetz. The Role of Procalcitonin for Risk Assessment and Treatment of COVID-19 Patients


Leave A Message

Leave A Message

    Please provide us with the information below, and we'll contact you as soon as possible.

Home

products

about

contact